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Abstract
Background and Aims: As our population ages and life expectancy increases the number of
people aged over 80 and more referred for cardiac surgery is growing. This study sought to identify
the outcome of aortic valve replacement (AVR) in octogenarians.
Methods: 68 patients aged 80 years or more underwent AVR at the Freeman Hospital, between
April 2001 and April 2004. A retrospective review of the notes and outcomes from the patients'
GP and the NHS strategic tracking service was performed. 54% (37) underwent isolated AVR whilst
46% (31) underwent combined AVR and CABG.
Results: Follow up was 100% complete. The mean age was 83.1 ± s.d. 2.9 years, a mean gradient
of 83 ± s.d. 31 mmHg and mean AVA of 0.56 cm2. The mean additive EuroSCORE was 8.6 ± s.d.
1.2, the logistic EuroSCORE mean 12.0 ± s.d. 5.9. In hospital 30 day mortality was 13 %. Survival
was 80% at 1 year and 78% at 2 years. Median follow up was for 712 days. Stepwise logistic
regression identified chronic obstructive airways disease as an independent predictor of mortality
(p < 0.05). Survival was not adversely affected by the addition of coronary artery bypass grafts to
aortic valve replacement, the presence of peripheral vascular disease, hypertension or diabetes. In
this study duration of cross clamp or bypass time were not found to reach significance as
independent predictors of mortality.
Conclusion: Our study demonstrates that the operative mortality for AVR in the over eighties is
good, whilst the mid to long term outcome is excellent There is a very low attrition rate with those
undergoing the procedure living as long than their age matched population. This study confirms
AVR is a safe, acceptable treatment for octogenarians with excellent mid term outcomes.
Background
Life expectancy for both men and women has continued
to rise in the UK. Data from 2002 shows life expectancy at
birth for females born in the UK was 81 years, compared
with 76 years for males. This contrasts with 49 and 45
years respectively at the turn of the last century. The expec-
tation of life for people reaching the age of 80 has also
increased and is now 7 years for men, 9 years for women
in the U.K. (OPCS data). Cardiovascular disease is the
largest cause of death in this age group. As our population
ages, the number of people aged 80 or over referred for
cardiac surgery is increasing with a particular rise in those
with aortic valve disease. There is evidence that early out-
comes in heart valve surgery are improving over the last
decade [1] Previous studies have demonstrated good out-
comes in terms of both operative mortality [2] and quality
of life [3]. Age has also been shown to influence the deci-
sion to refer patients with aortic stenosis for surgery [4]
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with adverse outcomes [5]. This study sought to identify
the medium term outcome of aortic valve replacement in
octogenarians in a more recent setting.
Methods
Between April 2001 and April 2004 all patients aged 80
years or more who underwent aortic valve replacement
(AVR) or AVR and coronary artery bypass grafts at a single
tertiary referral hospital in Northern England (Freeman
Hospital) were identified. The notes were retrospectively
reviewed. The patients' general practices were contacted to
obtain follow up data, together with the hospital PATS
database and the NHS strategic tracking service. Patients
undergoing double valve replacement were excluded.
Results
Sixty eight patients were identified. Data collection and
follow up were 100% complete. The mean age was 83.2 ±
s.d. 2.9 years, a mean gradient of 83 ± s.d. 31 mmHg and
mean AVA of 0.56 ± s.d. 0.24 cm2. Fifty four percent (37)
underwent isolated AVR whilst 46% underwent com-
bined AVR and CABG. (Table 1) All the patients had bio-
prostheses implanted. Two patients received stentless
valves. All but one patient underwent first time valve
replacement. One patient required root enlargement to
accommodate a size 19 prosthesis.
The mean additive EuroSCORE was 8.6 ± s.d. 1.2, the
mean logistic EuroSCORE was 12.0 ± s.d. 5.9, the mean
Parsonnet score was 30.4 ± s.d. 4.3. In hospital 7 day and
30 day mortality were 4.4% and 13% respectively. Iso-
lated AVR mortality was 10% at 30 days. Two patients
(3%) were affected by a CVA or TIA. Atrial fibrillation
occurred in 18 (26%), whilst seven patients required renal
replacement therapy as a new intervention postopera-
tively in the form of continuous veno-venous haemofiltra-
tion. Mean hospital stay was 15 ± s.d. 12 and median 11
days (range 5 to 60 days).  See table 2.
Survival was 80% at 1 year and 78% at 2 years, see Figure
1. Median follow up was for 712 days. Stepwise logistic
regression identified COAD as an independent predictor
of mortality (p < 0.05). Survival was not adversely affected
by the addition of coronary artery bypass grafts to aortic
valve replacement, the presence of peripheral vascular dis-
ease, hypertension or diabetes. In this study, duration of
cross clamp or bypass time were not found to reach signif-
icance as independent predictors of mortality.
Comment
The current demographic trend throughout the developed
world is for an ageing population with improved life
expectancy. Data from the Society of Cardiothoracic Sur-
geons of Great Britain and Ireland national audit 2003
shows the average age of patients in the UK undergoing
Survival curve for octogenarian aortic valve replacement Figure 1
Survival curve for octogenarian aortic valve replacement.
Table 1: Demographics, symptoms, risk factors
Variable (unit) n (percentage)
Male 38 (58%)
Mean Age ± s.d. (years) 83.2 ± 2.9
NYHA I 7 (11%)
II 13 (21%)
III 29 (46%)
IV 14 (22%)
CCS 0 26 (42%)
I8  ( 1 3 % )
II 11 (18%)
III 14 (23%)
IV 3 (5%)
Impaired LV 11 (18%)
NIDDM 3 (4%)
Hypertension 29 (43%)
Renal Impairment/Failure 6 (9%)
COPD 12 (18%)
PVD 5 (8%)
Emergent/Urgent 18 (26%)
CCS – Canadian Cardiovascular Society
COPD – Chronic obstructive pulmonary disease
NYHA – New York Heart Association
LV – Left ventricle
NIDDM – Non insulin dependent diabetes mellitus
PVD – Peripheral vascular diseasePublish with BioMed Central    and   every 
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combined AVR and CABG has risen from 68 to just under
72 with a similar trend for isolated AVR [6].
Aortic valve replacement has been shown to be the most
common valve surgery performed in this age group [7].
The simple additive Euroscore significantly under-pre-
dicted 30 day mortality in this sub-group of the general
cardiothoracic patient population, with a mean Euroscore
of 8.3. The mean logistic Euroscore was 12.0, which was
closer to the actual mortality in this study. Previous stud-
ies have suggested that coronary artery bypass grafting
combined with aortic valve replacement does not increase
post operative risk [8], which is supported by our results.
Our study demonstrates that the operative mortality for
AVR in the over eighties is good, whilst the mid to long
term outcome is excellent. There is a very low attrition rate
with those undergoing the procedure living as long as
their age matched population. This study confirms AVR is
a safe, acceptable treatment for selected octogenarians
with excellent mid term outcomes. A surgical opinion
should not therefore be withheld on the basis of age.
Limitations
This is a small retrospective study which purely looked at
hospital morbidity and mortality. Follow up mortality
data was collected but there was no assessment of quality
of life or symptom status in this data. A selection bias has
not been excluded in this group proceeding to surgery.
Perhaps because they were so carefully selected median
survival was excellent.
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Table 2: Post operative complications
Complication n (percentage)
Atrial Fibrillation 18 (26%)
Renal Support (new CVVH) 7 (10%)
Respiratory Failure 12 (18%)
Bleeding requiring reopening 3 (4%)
CVA 1 (1%)
TIA 1 (1%)
CVA – Cerebro-vascular Accident
TIA – Transient Ischaemic Attack